Inhibition of Helicobacter pylori and Its Associated Urease by Two Regional Plants of San Luis Argentina

Ibáñez, Ángel Gabriel Salinas; Sosa, A.C. Arismendi; Ferramola, F.F.; Paredes, Joffre Enrique León; Wendel, Graciela Haydée; Maria, A.O.; Vega, Alba Edith

doi:10.20546/ijcmas.2017.609.258

Cited by 5 publications

(6 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Celecoxib inhibited H. pylori motility by decreasing mRNA expression of the fla A gene, but the ure A gene was upregulated ( 59 ). The aqueous extracts of Litrahea molleoides and Aristolochia argentina , two native plants of the Province of San Luis, Argentina, were able to downregulate the expression of the ure A gene from H. pylori cultures ( 20 ). Several authors have reported that honey, polyphenols, flavonoids, thiourea, dihydroxyacetone, and sulforaphane were able to inhibit the urease activity ( 60 – 62 ).…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Antimicrobial Effect of a Proteolytic Enzyme From the Fruits of Solanum granuloso-leprosum (Dunal) Against Helicobacter pylori

et al. 2021

View full text Add to dashboard Cite

Helicobacter pylori is a gram-negative, helix-shaped, and microaerophilic bacteria that colonizes the human gastric mucosa, causing chronic infections, gastritis, peptic ulcer, lymphomas associated with lymphoid mucosa tissue, and gastric cancer. H. pylori is considered a Type 1 human carcinogen by WHO. The prevalence of the infection is estimated in more than half of the world population. Treatment of H. pylori infection includes antibiotics and proton pump inhibitors, but the increasing antibiotic resistance promotes the research of novel, more effective, and natural antibacterial compounds. The aim of this work was to study the effect of the partially purified proteolytic extract (RAP) of the fruits from Solanum granuloso-leprosum (Dunal), a South American native plant, and a purified fraction named granulosain I, against H. pylori, to obtain natural food additives for the production of anti-H. pylori functional foods. Furthermore, granulosain I and RAP could be used as natural adjuncts to conventional therapies. Granulosain I and RAP antibacterial activity was evaluated as minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) against H. pylori NCTC 11638 (reference strain) and twelve H. pylori wild strains, using a microdilution plating technique (Clinical and Laboratory Standards Institute). All the strains tested were susceptible to granulosain I with MIC from 156.25 to 312.5 μg/mL and MBC from 312.5 to 625 μg/mL, respectively. Besides, all the strains tested were susceptible to the RAP with MIC from 312.5 to 625 μg/mL and MBC from 625 to 1,250 μg/mL, respectively. The effect of granulosain I and RAP on the transcription of H. pylori genes encoding pathogenic factors, omp18, ureA, and flaA, with respect to a housekeeping gene (16S rRNA), was evaluated by RT-PCR technique. The band intensity between pathogenic factors and control gene was correlated under treated or untreated conditions, using the ImageJ program. Granulosain I and RAP significantly decreased the expression of pathogenic factors: omp18, ureA, and flaA. The combined inhibitory effect of granulosain I or RAP and an antibiotic such as, amoxicillin (AML, 10 μg), clarithromycin (CLA, 15 μg), levofloxacin (LEV, 5 μg), and metronidazole (MTZ, 5 μg) was evaluated, using the agar diffusion technique. Granulosain I and RAP showed significant synergistic effect on AML, CLA, and LEV, but no significant effect on MTZ was observed. Besides, granulosain I and RAP did not show toxicological effects at the concentrations studied. Finally, granulosain I and RAP could be used as safe natural food additives and as adjuvants for conventional therapies against H. pylori.

show abstract

Section: Resultsmentioning

confidence: 99%

“…New effective and safe natural antibacterial compounds that can act on the H. pylori targets or modulate the host's immune system are actively sought. The use of plant extracts and their derivatives constitutes an emerging therapeutic approach ( 20 , 21 ).…”

Section: Introductionmentioning

confidence: 99%

Antimicrobial Effect of a Proteolytic Enzyme From the Fruits of Solanum granuloso-leprosum (Dunal) Against Helicobacter pylori

et al. 2021

View full text Add to dashboard Cite

show abstract

“…The antibacterial activity of asclepain cI against H. pylori strains was evaluated using the broth microdilution method as previously described by Bang et al ( 2015 ), Salinas Ibáñez et al ( 2017 ). Asclepain cI concentration ranging from 32 to 0.125 μg of protein/ml was used and 2,3,5-triphenyl tetrazolium chloride (TTC, Merck KGaA, Darmstadt, Germany) solution was added as a viability indicator.…”

Section: Methodsmentioning

confidence: 99%

“…Gene expression assays were evaluated with SubMICs (½ MIC) of asclepain cI. Total RNA was isolated from cultures of 13 strains with or without enzyme treatment, using TRIZOL reagent according to the manufacturer's instructions (Invitrogen, Buenos Aires, Argentina), being stored at −20 • C. The cDNA was obtained as previously described by Salinas Ibáñez et al (2017).…”

Section: Primermentioning

confidence: 99%

See 1 more Smart Citation

Asclepain cI, a proteolytic enzyme from Asclepias curassavica L., a south American plant, against Helicobacter pylori

et al. 2022

View full text Add to dashboard Cite

Helicobacter pylori is a Gram negative bacterium most frequently associated with human gastrointestinal infections worldwide. The increasing occurrence of antibiotic-resistant isolates of H. pylori constitutes a challenge. The eradication of the microorganism is currently being considered a “high priority” by the World Health Organization (WHO). In this context, bioactive compounds found in natural products seem to be an effective therapeutic option to develop new antibiotics against the pathogen. In this study, we investigated the effect of asclepain cI, the main purified proteolytic enzyme of the latex of petioles and stems from Asclepia curassavica L. (Asclepiadaceae), a South American native plant, against H. pylori; in order to obtain a natural therapeutic adjuvant and a safe nutraceutical product. Asclepain cI showed antibacterial activity against reference strains and drug-resistant clinical isolates of H. pylori in vitro. A range of minimal inhibitory concentration (MIC) from 1 to 2 μg/ml and minimal bactericidal concentration (MBC) from 2 to 4 μg/ml was obtained, respectively. The action of asclepain cI on the transcription of omp18, ureA, flaA genes showed a significantly decreased expression of the selected pathogenic factors. Furthermore, asclepain cI did not induce toxic effects at the concentrations assayed. Asclepain cI could be considered a highly feasible option to be used as a natural therapeutic adjuvant and a safe nutraceutical product against H. pylori.

show abstract

Lithraea molleoides (Vell.) Engler

López

Basile

Wallace

et al. 2021

Medicinal and Aromatic Plants of the World

View full text Add to dashboard Cite

Inhibition of Helicobacter pylori and Its Associated Urease by Two Regional Plants of San Luis Argentina

Cited by 5 publications

References 18 publications

Antimicrobial Effect of a Proteolytic Enzyme From the Fruits of Solanum granuloso-leprosum (Dunal) Against Helicobacter pylori

Antimicrobial Effect of a Proteolytic Enzyme From the Fruits of Solanum granuloso-leprosum (Dunal) Against Helicobacter pylori

Asclepain cI, a proteolytic enzyme from Asclepias curassavica L., a south American plant, against Helicobacter pylori

Lithraea molleoides (Vell.) Engler

Contact Info

Product

Resources

About